Compare FENC & LPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FENC | LPRO |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 258.5M | 252.9M |
| IPO Year | 2001 | N/A |
| Metric | FENC | LPRO |
|---|---|---|
| Price | $7.57 | $1.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $13.50 | $2.83 |
| AVG Volume (30 Days) | 196.5K | ★ 545.6K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $38,790,000.00 | $16,948,000.00 |
| Revenue This Year | N/A | $306.66 |
| Revenue Next Year | $75.22 | $7.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.68 | $0.70 |
| 52 Week High | $9.92 | $6.75 |
| Indicator | FENC | LPRO |
|---|---|---|
| Relative Strength Index (RSI) | 42.20 | 46.29 |
| Support Level | $7.35 | $1.77 |
| Resistance Level | $7.74 | $1.81 |
| Average True Range (ATR) | 0.36 | 0.10 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 20.00 | 20.00 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Open Lending Corp is engaged in providing automated lending services to financial institutions. The company offers loan analytics, risk-based pricing, risk modeling, and automated decision technology. Its Lenders Protection Program ("LPP") enables automotive lenders to make loans that are largely insured against, losses from defaults.